A randomized, double-blind, placebo-controlled crossover trial of valacyclovir for suppression of HSV (herpes simplex virus) and HIV shedding in HIV-1, HSV-2 coinfected men who have sex with men (MSM)
Phase of Trial: Phase III
Latest Information Update: 09 Mar 2010
At a glance
- Drugs Valaciclovir (Primary)
- Indications Herpes simplex virus type 2 infections; HIV-1 infections
- Focus Pharmacodynamics
- 15 Oct 2006 New trial record.